<?xml version="1.0" encoding="UTF-8"?>
<ref id="CR23">
 <label>23.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Wolchok</surname>
    <given-names>JD</given-names>
   </name>
   <name>
    <surname>Kluger</surname>
    <given-names>H</given-names>
   </name>
   <name>
    <surname>Callahan</surname>
    <given-names>MK</given-names>
   </name>
   <name>
    <surname>Postow</surname>
    <given-names>MA</given-names>
   </name>
   <name>
    <surname>Rizvi</surname>
    <given-names>NA</given-names>
   </name>
   <name>
    <surname>Lesokhin</surname>
    <given-names>AM</given-names>
   </name>
   <etal/>
  </person-group>
  <article-title>Nivolumab plus ipilimumab in advanced melanoma</article-title>
  <source>N Engl J Med</source>
  <year>2013</year>
  <volume>369</volume>
  <fpage>122</fpage>
  <lpage>133</lpage>
  <pub-id pub-id-type="doi">10.1056/NEJMoa1302369</pub-id>
  <?supplied-pmid 23724867?>
  <pub-id pub-id-type="pmid">23724867</pub-id>
 </element-citation>
</ref>
